Navigation Links
Elekta Launches New Version of Monaco Treatment Planning System with Segment Shape Optimization
Date:9/19/2012

ATLANTA, Sept. 19, 2012 /PRNewswire/ -- Elekta recently announced the latest production release of its Monaco® treatment planning system, version 3.20, which offers customers improved VMAT planning and delivery support in addition to support for Elekta's Agility™* 160-leaf multi-leaf collimator. This release promises to create new workflow efficiencies through integrated plan approval and enhanced integration with MOSAIQ® Oncology Information System.

The new Segment Shape Optimization™ is driving improved dose conformity, plan quality and delivery efficiency through its proprietary approach to smoothing and clustering segments then optimizing beam weights and shapes. Powered by the Monte Carlo algorithm, the results are plans that improve sparing of organs-at-risk and dose conformality.

In addition, the release's new contouring tool, EZ Sketch, and Room's Eye View increase workflow efficiency. Support for Agility means that Monaco 3.20 users can achieve a new level of beam-shaping precision and delivery speed.

Staff at Kettering Medical Center (Dayton, Ohio) used a pilot version of Monaco 3.20.

"We have been using Monaco 3.20 clinically since June 2012," says Christopher Wennerstrom, MS, DABR, Medical Physicist at Kettering Medical Center. "It has consistently provided excellent tumor coverage while meeting our physicians' very strict OAR tolerances. The new Target Penalty cost function and segment shape optimizer allow us to treat more patients with VMAT than ever before, and even our most complex SBRT cases have extremely quick treatment times."

Monaco is a state-of-the-art IMRT, VMAT and SBRT planning solution that features innovative biological cost functions with multi-criterial constrained optimization, a powerful leaf sequence optimizer and a robust Monte Carlo dose calculation algorithm. Monaco helps make the planning process easier, more straightforward and clinica
'/>"/>

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
2. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
3. Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research
4. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
5. U.K. Cancer Patient is Worlds First to Benefit from Treatment Combining Elektas New Beam-shaping Innovation and High-speed Arc Therapy
6. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
7. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
8. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
9. ASRT Foundation and Elekta Award More Than $20,000 in Scholarships to Radiation Therapy Students
10. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
11. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements ... announced tender offer by its indirect wholly-owned subsidiary, Sapphire ... of common stock of Solta Medical, Inc. (NASDAQ: ...
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly ... and painless for patients to self-inject prescription drugs in the ... including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... grow to $220B by 2018, according to analysts.   Many of ...
(Date:1/14/2014)... HILLS, Calif. , Jan. 14, 2014 The Brandeis Medical ... Los Angeles a premier and affordable laser tattoo removal ... special. Dr. Brandeis, focus is in providing high quality cosmetic services ... all patients. " Southern California has ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... SOUTHAMPTON, England, March 24 , ... Completes Phase I Dosing , ... medical needs, announces further clinical trial progress with its ... hypertrophy (BPH) and VA111913 for dysmenorrhoea. The Phase IIa,trial ...
... today announced positive results from a Phase 1 trial ... in vitro anti-pseudomonal activity. The results from ... well tolerated, with a clinical and laboratory safety profile ... toxicity was observed, even at the highest dose regimen ...
Cached Medicine Technology:Vantia Therapeutics' Pipeline Continues to Mature 2Vantia Therapeutics' Pipeline Continues to Mature 3Vantia Therapeutics' Pipeline Continues to Mature 4Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity 2
(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... (Chicago) A recently FDA-approved device has been shown ... as much as 50 percent. When coupled with an ... Rush, the device facilitated the complete elimination of seizures ... in the decade-long clinical trials. , That,s good news ... in the U.S. living with epilepsy whose seizures can,t ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
Breaking Medicine News(10 mins):Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
... published in the August issue of the American Journal ... multidetector computed tomography (MDCT) in diagnosing// the spread of ... MDCT on 69 patients to examine the efficiency of ... of the 44 cases, while MDCT correctly diagnosed 27. ...
... at a local hospital in Tulungagung, East Java, became ... yesterday.// Runizar Ruesin from the health ministry's bird flu ... with dead chickens. ,Local tests confirmed that ... to deal with bird flu infection and the human ...
... September is the World Heart Day. The theme for the ... all, especially the youth//, to follow a health-friendly regime and ... ,A healthy heart is the foundation to a healthy ... to a healthy life. The booming IT industry, with its ...
... of Fresno, is going through a rough patch, following a ... was enforced after three children from South California took ill ... the State’s charge said "There's a lot of confusion. The ... it's an over-reaction." , ,The State Department of Food ...
... to focus more on healthy eating could be accomplished ... children to eat healthier food could lead to clashes ... has been unveiled by the government which is aimed ... to shorter life expectancies in the younger generation than ...
... Health & Science University's (OHSU) Doernbecher Children's Hospital, the ... to cure Batten disease// is set to get underway ... but deadly neurodegenerative disorder. A phase I trial is ... of its efficacy.,According to the researchers, the transplants of ...
Cached Medicine News:Health News:Healthy Heart for a Hearty Life 2Health News:$67m to Tackle Obesity 2Health News:Stem cell trial to beat Batten Disease 2Health News:Stem cell trial to beat Batten Disease 3
Fine pointed grooved jaws with smooth curve from tip to finger grip style handle. Dull finish....
This forcep was designed to eliminate the occasional tearing of tissue which may occur when grasping the lips of an incision with a traditional. 12 forceps. The rows of blunt teeth are gentle yet pro...
Straight shafts with 1 x 2 teeth. Flat handle with polished finish....
Straight shafts with 90 degrees, 2 x 3 teeth and tying platform. Serrated handle with polished finish. Most popular size or model....
Medicine Products: